# A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea

> **NCT03796026** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 34 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Seltorexant 40 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03796026
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-04
- **Primary completion:** 2019-06-07
- **Final completion:** 2019-06-14
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796026, "A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03796026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*